Literature DB >> 7943043

Regional localisation of a non-specific X-linked mental retardation gene (MRX19) to Xp22.

A J Donnelly1, K H Choo, H M Kozman, A K Gedeon, D M Danks, J C Mulley.   

Abstract

A gene responsible for a non-specific form of X-linked mental retardation (MRX19) was localised by linkage analysis. Exclusions and regional localisation were made using 21 highly informative PCR-based markers along the X chromosome. Significant lod scores at a recombination fraction of zero were detected with the marker loci DXS207, DXS987 (Zmax = 3.58) and DXS999 (Zmax = 3.28) indicating that this gene is localised to the proximal portion of Xp22. Recombination between MRX19 and the flanking loci KAL and DXS989 was observed. The multipoint CEPH background map, with map distances in cM, is DXS996-1.8-KAL-19.0-DXS207-0.9-[DXS987,DXS443 ]-4.3-DXS999-3.5-DXS365-14.0-DXS989. Two other MRX disorders and two syndromal mental retardations, Coffin-Lowry syndrome and Partington syndrome, have been mapped to this region. There is a possibility that the 3 MRX disorders are the same entity. Most MRX disorders remain clustered around the pericentromeric region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943043     DOI: 10.1002/ajmg.1320510457

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.

Authors:  M Field; P Tarpey; J Boyle; S Edkins; J Goodship; Y Luo; J Moon; J Teague; M R Stratton; P A Futreal; R Wooster; F L Raymond; G Turner
Journal:  Clin Genet       Date:  2006-12       Impact factor: 4.438

2.  Localisation of a new gene for non-specific mental retardation to Xq22-q26 (MRX35).

Authors:  X X Gu; R Decorte; P Marynen; J P Fryns; J J Cassiman; P Raeymaekers
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

Review 3.  Coffin-Lowry syndrome: clinical and molecular features.

Authors:  A Hanauer; I D Young
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.